AstraZeneca PLC Valuation
| AZN Stock | USD 68.73 0.20 0.29% |
At this time, the firm appears to be undervalued. AstraZeneca PLC ADR shows a prevailing Real Value of $75.24 per share. The current price of the firm is $68.73. Our model approximates the value of AstraZeneca PLC ADR from analyzing the firm fundamentals such as Profit Margin of 0.13 %, return on equity of 0.16, and Current Valuation of 130.66 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting AstraZeneca PLC's valuation include:
Price Book 5.4598 | Enterprise Value 130.7 B | Enterprise Value Ebitda 17.7384 | Price Sales 4.6651 | Forward PE 16.3132 |
Undervalued
Today
Please note that AstraZeneca PLC's price fluctuation is very steady at this time. Calculation of the real value of AstraZeneca PLC ADR is based on 3 months time horizon. Increasing AstraZeneca PLC's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for AstraZeneca PLC ADR is useful when determining the fair value of the AstraZeneca stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of AstraZeneca PLC. Since AstraZeneca PLC is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AstraZeneca Stock. However, AstraZeneca PLC's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 68.73 | Real 75.24 | Target 83.71 | Hype 68.75 |
The real value of AstraZeneca Stock, also known as its intrinsic value, is the underlying worth of AstraZeneca PLC ADR Company, which is reflected in its stock price. It is based on AstraZeneca PLC's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of AstraZeneca PLC's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence AstraZeneca PLC's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of AstraZeneca PLC ADR helps investors to forecast how AstraZeneca stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AstraZeneca PLC more accurately as focusing exclusively on AstraZeneca PLC's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AstraZeneca PLC's intrinsic value based on its ongoing forecasts of AstraZeneca PLC's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AstraZeneca PLC's closest peers. When choosing an evaluation method for AstraZeneca PLC ADR, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
AstraZeneca PLC Investments |
|
AstraZeneca Valuation Drivers Correlation
Many accounts on the financial statements of AstraZeneca PLC ADR are highly interrelated and sometimes correlated. Consequently, when conducting AstraZeneca's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of AstraZeneca
Click cells to compare fundamentals
AstraZeneca Valuation Trend
Knowing AstraZeneca PLC's actual value is paramount for traders to make sound investment determinations. AstraZeneca PLC's real value is not only important for the investor to make better decisions but also for a more accurate overall view of AstraZeneca PLC's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both AstraZeneca PLC's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
AstraZeneca Market Cap
AstraZeneca PLC ADR is number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is presently estimated at about 264.86 Billion. AstraZeneca PLC totals roughly 213.71 Billion in market capitalization claiming about 81% of equities under Health Care industry.AstraZeneca PLC Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining AstraZeneca PLC's current stock value. Our valuation model uses many indicators to compare AstraZeneca PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AstraZeneca PLC competition to find correlations between indicators driving AstraZeneca PLC's intrinsic value. More Info.AstraZeneca PLC ADR is rated third in price to earning category among related companies. It is rated second in price to book category among related companies fabricating about 0.05 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for AstraZeneca PLC ADR is roughly 18.94 . As of the 16th of April 2024, Price To Book Ratio is likely to grow to 9.53. Comparative valuation analysis is a catch-all model that can be used if you cannot value AstraZeneca PLC by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AstraZeneca PLC's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AstraZeneca PLC's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AstraZeneca PLC's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AstraZeneca PLC and how it compares across the competition.
About AstraZeneca PLC Valuation
The stock valuation mechanism determines the current worth of AstraZeneca PLC ADR on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC ADR. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of AstraZeneca PLC ADR based exclusively on its fundamental and basic technical indicators. By analyzing AstraZeneca PLC's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of AstraZeneca PLC's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of AstraZeneca PLC. We calculate exposure to AstraZeneca PLC's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to AstraZeneca PLC's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 37.5 B | 19.9 B | |
| Pretax Profit Margin | 0.15 | 0.20 | |
| Operating Profit Margin | 0.18 | 0.22 | |
| Net Profit Margin | 0.13 | 0.10 | |
| Gross Profit Margin | 0.82 | 0.87 |
8 Steps to conduct AstraZeneca PLC's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AstraZeneca PLC's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AstraZeneca PLC's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AstraZeneca PLC's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AstraZeneca PLC's revenue streams: Identify AstraZeneca PLC's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AstraZeneca PLC's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AstraZeneca PLC's growth potential: Evaluate AstraZeneca PLC's management, business model, and growth potential.
- Determine AstraZeneca PLC's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AstraZeneca PLC's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
A single share of AstraZeneca PLC represents a small ownership stake in the entity. As a stockholder of AstraZeneca, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
AstraZeneca PLC Dividends Analysis For Valuation
As of the 16th of April 2024, Dividend Yield is likely to grow to 0.03, though Dividends Paid is likely to grow to (4.3 B). . At this time, AstraZeneca PLC's Earnings Yield is very stable compared to the past year. As of the 16th of April 2024, Price Earnings Ratio is likely to grow to 58.74, while Retained Earnings are likely to drop about 1.4 B.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | -4.5 B | -4.3 B | |
| Dividend Yield | 0.02 | 0.03 | |
| Dividend Payout Ratio | 0.75 | 0.71 | |
| Dividend Paid And Capex Coverage Ratio | 14.72 | 13.14 |
There are various types of dividends AstraZeneca PLC can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of AstraZeneca shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from AstraZeneca PLC ADR directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When AstraZeneca pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of AstraZeneca PLC by the value of the dividends paid out.
AstraZeneca PLC Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as AstraZeneca PLC does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.1 B | |
| Quarterly Earnings Growth Y O Y | 0.059 | |
| Forward Price Earnings | 16.3132 |
AstraZeneca PLC Current Valuation Indicators
Valuation refers to the process of determining the present value of AstraZeneca PLC ADR and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value AstraZeneca we look at many different elements of the entity such as AstraZeneca's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. AstraZeneca PLC's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final AstraZeneca PLC's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AstraZeneca PLC, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AstraZeneca PLC's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AstraZeneca PLC's worth.When determining whether AstraZeneca PLC ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AstraZeneca PLC's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Astrazeneca Plc Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Astrazeneca Plc Adr Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AstraZeneca PLC ADR information on this page should be used as a complementary analysis to other AstraZeneca PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for AstraZeneca Stock analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is AstraZeneca PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.059 | Dividend Share 2.9 | Earnings Share 1.9 | Revenue Per Share 2.4547 | Quarterly Revenue Growth 0.073 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.